Clinical Trials Browser

Phase 3 × INDUSTRY × futuximab × Clear all

NCT05223673 2024-08-20

COLSTAR

Phase 3 Terminated

7 enrolled 12 charts

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT03717038 2019-02-04

Sym004 Versus TAS-102 in Patients With mCRC

Phase 3 Withdrawn

Gastrointestinal

Carcinoma, Colorectal Neoplasms